These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

670 related articles for article (PubMed ID: 16129833)

  • 21. Progeria, the nucleolus and farnesyltransferase inhibitors.
    Mehta IS; Bridger JM; Kill IR
    Biochem Soc Trans; 2010 Feb; 38(Pt 1):287-91. PubMed ID: 20074076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Permanent farnesylation of lamin A mutants linked to progeria impairs its phosphorylation at serine 22 during interphase.
    Moiseeva O; Lopes-Paciencia S; Huot G; Lessard F; Ferbeyre G
    Aging (Albany NY); 2016 Feb; 8(2):366-81. PubMed ID: 26922519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lamin A, farnesylation and aging.
    Reddy S; Comai L
    Exp Cell Res; 2012 Jan; 318(1):1-7. PubMed ID: 21871450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emerging candidate treatment strategies for Hutchinson-Gilford progeria syndrome.
    Strandgren C; Revêchon G; Sola-Carvajal A; Eriksson M
    Biochem Soc Trans; 2017 Dec; 45(6):1279-1293. PubMed ID: 29127216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increasing the length of progerin's isoprenyl anchor does not worsen bone disease or survival in mice with Hutchinson-Gilford progeria syndrome.
    Davies BS; Yang SH; Farber E; Lee R; Buck SB; Andres DA; Spielmann HP; Agnew BJ; Tamanoi F; Fong LG; Young SG
    J Lipid Res; 2009 Jan; 50(1):126-34. PubMed ID: 18757838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vitamin D receptor signaling improves Hutchinson-Gilford progeria syndrome cellular phenotypes.
    Kreienkamp R; Croke M; Neumann MA; Bedia-Diaz G; Graziano S; Dusso A; Dorsett D; Carlberg C; Gonzalo S
    Oncotarget; 2016 May; 7(21):30018-31. PubMed ID: 27145372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activating the synthesis of progerin, the mutant prelamin A in Hutchinson-Gilford progeria syndrome, with antisense oligonucleotides.
    Fong LG; Vickers TA; Farber EA; Choi C; Yun UJ; Hu Y; Yang SH; Coffinier C; Lee R; Yin L; Davies BS; Andres DA; Spielmann HP; Bennett CF; Young SG
    Hum Mol Genet; 2009 Jul; 18(13):2462-71. PubMed ID: 19376814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An overview of treatment strategies for Hutchinson-Gilford Progeria syndrome.
    Harhouri K; Frankel D; Bartoli C; Roll P; De Sandre-Giovannoli A; Lévy N
    Nucleus; 2018 Jan; 9(1):246-257. PubMed ID: 29619863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Defective lamin A-Rb signaling in Hutchinson-Gilford Progeria Syndrome and reversal by farnesyltransferase inhibition.
    Marji J; O'Donoghue SI; McClintock D; Satagopam VP; Schneider R; Ratner D; Worman HJ; Gordon LB; Djabali K
    PLoS One; 2010 Jun; 5(6):e11132. PubMed ID: 20559568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dermal fibroblasts in Hutchinson-Gilford progeria syndrome with the lamin A G608G mutation have dysmorphic nuclei and are hypersensitive to heat stress.
    Paradisi M; McClintock D; Boguslavsky RL; Pedicelli C; Worman HJ; Djabali K
    BMC Cell Biol; 2005 Jun; 6():27. PubMed ID: 15982412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular Smooth Muscle-Specific Progerin Expression Accelerates Atherosclerosis and Death in a Mouse Model of Hutchinson-Gilford Progeria Syndrome.
    Hamczyk MR; Villa-Bellosta R; Gonzalo P; Andrés-Manzano MJ; Nogales P; Bentzon JF; López-Otín C; Andrés V
    Circulation; 2018 Jul; 138(3):266-282. PubMed ID: 29490993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progerin-Induced Replication Stress Facilitates Premature Senescence in Hutchinson-Gilford Progeria Syndrome.
    Wheaton K; Campuzano D; Ma W; Sheinis M; Ho B; Brown GW; Benchimol S
    Mol Cell Biol; 2017 Jul; 37(14):. PubMed ID: 28483909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interruption of progerin-lamin A/C binding ameliorates Hutchinson-Gilford progeria syndrome phenotype.
    Lee SJ; Jung YS; Yoon MH; Kang SM; Oh AY; Lee JH; Jun SY; Woo TG; Chun HY; Kim SK; Chung KJ; Lee HY; Lee K; Jin G; Na MK; Ha NC; Bárcena C; Freije JM; López-Otín C; Song GY; Park BJ
    J Clin Invest; 2016 Oct; 126(10):3879-3893. PubMed ID: 27617860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reversal of age-dependent nuclear morphology by inhibition of prenylation does not affect lifespan in Caenorhabditis elegans.
    Bar DZ; Gruenbaum Y
    Nucleus; 2010; 1(6):499-505. PubMed ID: 21327093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A farnesyltransferase inhibitor prevents both the onset and late progression of cardiovascular disease in a progeria mouse model.
    Capell BC; Olive M; Erdos MR; Cao K; Faddah DA; Tavarez UL; Conneely KN; Qu X; San H; Ganesh SK; Chen X; Avallone H; Kolodgie FD; Virmani R; Nabel EG; Collins FS
    Proc Natl Acad Sci U S A; 2008 Oct; 105(41):15902-7. PubMed ID: 18838683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reversal of the cellular phenotype in the premature aging disease Hutchinson-Gilford progeria syndrome.
    Scaffidi P; Misteli T
    Nat Med; 2005 Apr; 11(4):440-5. PubMed ID: 15750600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MG132-induced progerin clearance is mediated by autophagy activation and splicing regulation.
    Harhouri K; Navarro C; Depetris D; Mattei MG; Nissan X; Cau P; De Sandre-Giovannoli A; Lévy N
    EMBO Mol Med; 2017 Sep; 9(9):1294-1313. PubMed ID: 28674081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Towards a Drosophila model of Hutchinson-Gilford progeria syndrome.
    Beard GS; Bridger JM; Kill IR; Tree DR
    Biochem Soc Trans; 2008 Dec; 36(Pt 6):1389-92. PubMed ID: 19021561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nuclear lamins and progerin are dispensable for antioxidant Nrf2 response to arsenic and cadmium.
    Hashimoto K; Majumdar R; Tsuji Y
    Cell Signal; 2017 May; 33():69-78. PubMed ID: 28229933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progerin sequestration of PCNA promotes replication fork collapse and mislocalization of XPA in laminopathy-related progeroid syndromes.
    Hilton BA; Liu J; Cartwright BM; Liu Y; Breitman M; Wang Y; Jones R; Tang H; Rusinol A; Musich PR; Zou Y
    FASEB J; 2017 Sep; 31(9):3882-3893. PubMed ID: 28515154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.